IMMERSE: Innovative Malaria M&E, Research and Surveillance towards Elimination: S

沉浸：创新型疟疾 M

• 批准号: 8848543
• 负责人: Sylvia Meek
• 金额: $ 35.33万
• 依托单位: MALARIA CONSORTIUM
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-01 至 2018-08-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8848543
• 关键词: IMMERSE; Innovative; Malaria; M&E; Research

DESCRIPTION (provided by applicant): The aim of this program is to improve malaria program implementation in the Greater Mekong Sub-region (GMS) (with a particular focus on Myanmar, Cambodia and Thailand), and build a robust and reliable evidence platform capable of developing and evaluating operational research, surveillance, and monitoring & evaluation (M&E) activities to inform policies and practices in conjunction with national malaria control programs and other partners. The specific aims are as follows: Develop and refine M&E and surveillance tools in order to assess the impact of existing interventions, monitor short-term malaria burden and transmission trends and inform programs on when to move from control to elimination strategies. To monitor artemisinin and artemisinin combination therapy ACT resistance using innovative approaches to conduct a series of OR activities to assess country-specific feasibility of malaria active case detection interventions, evaluation of innovative delivery mechanisms to target hard to reach populations and point of care diagnostics. Promote use of knowledge by local and national policy makers and program planners ensuring strategic information is disseminated and shared among GMS and sub-Saharan Africa (SSA), and best practices harmonized in the region. The principal approach will be to strengthen national programs capacity to move from malaria control to elimination and to support artemisinin resistance containment through the implementation and use of robust and innovative M&E, surveillance, and operational research. Malaria Consortium works closely with national malaria programs and partners through provision of technical assistance and implementation support. We shall focus on operationalizing the useful tools and promoting their uptake. In addition to its own team MC will engage key technical assistance from London School of Hygiene & Tropical Medicine and Institute Pasteur in Cambodia as well as some independent consultants, and if savings are made, MC will also engage Health Poverty Action for work in the special regions of eastern Burma. We shall work in strong collaboration with CDC and with WHO, and shall provide technical support also when needed to other PMI supported programs. By the end of the program we expect that a much higher standard of surveillance will be fully operational in partner countries, and key responses to malaria problem areas will be designed and implemented.

描述(由申请人提供)： 该计划的目的是改善大湄公河次区域(GMS)(特别是缅甸、柬埔寨和泰国)疟疾项目的实施，并建立一个强大而可靠的证据平台，能够开发和评估业务研究、监测和监测与评估(M&E)活动，以便与国家疟疾控制项目和其他合作伙伴一起为政策和实践提供信息。具体目标如下：开发和完善监测、评估和监测工具，以评估现有干预措施的影响，监测疟疾短期负担和传播趋势，并告知方案何时从控制战略转向消除战略。利用创新办法监测青蒿素和青蒿素联合疗法的抗药性，开展一系列OR活动，以评估疟疾活跃病例发现干预措施针对具体国家的可行性，评估针对难以接触到的人群的创新交付机制和护理点诊断。促进地方和国家政策制定者和计划规划者利用知识，确保在大湄公河次区域和撒哈拉以南非洲(SSA)之间传播和共享战略信息，并协调该地区的最佳做法。主要方法将是加强国家方案从疟疾控制转向消除疟疾的能力，并通过实施和使用强有力和创新的监测和业务研究来支持青蒿素耐药性的遏制。疟疾联合会通过提供技术援助和实施支持，与国家疟疾规划和合作伙伴密切合作。我们将把重点放在将有用的工具付诸实施并促进它们的使用上。除了自己的团队外，MC还将聘请来自柬埔寨伦敦卫生与热带医学院和巴斯德研究所的关键技术援助，以及一些独立顾问，如果节省资金，MC还将参与缅甸东部特殊地区的卫生扶贫行动。我们将与疾控中心和世卫组织密切合作，并在需要时为其他由PMI支持的项目提供技术支持。到该计划结束时，我们预计将在伙伴国家全面实施更高标准的监测，并将设计和实施针对疟疾问题地区的关键应对措施。